Related Experiment Video
Updated: Sep 6, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Comprehensive analysis of the novel omicron receptor AXL in cancers
Wei-Na Zhang1, Xue-Ping Li2,3, Peng-Fei Wang1
1Department of Hematology, Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China.
Abstract:
The SARS-CoV-2 is constantly mutating, and the new coronavirus such as Omicron has spread to many countries around the world. Anexelekto (AXL) is a transmembrane protein with biological functions such as promoting cell growth, migration, aggregation, metastasis and adhesion, and plays an important role in cancers and coronavirus disease 2019 (COVID-19). Unlike angiotensin-converting enzyme 2 (ACE2), AXL was highly expressed in respiratory system cells. In this study, we verified the AXL expression in cancer and normal tissues and found AXL expression was strongly correlated with cancer prognosis, tumor mutation burden (TMB), the microsatellite instability (MSI) in most tumor types. Immune infiltration analysis also demonstrated that there was an inextricable link between AXL expression and immune scores in cancer patients, especially in BLCA, BRCA and CESC. The NK-cells, plasmacytoid dendritic cells, myeloid dendritic cells, as one of the important components of the tumor microenvironment, were highly expressed AXL. In addition, AXL-related tumor neoantigens were identified and might provide the novel potential targets for tumor vaccines or SARS-Cov-2 vaccines research in cancer patients.
Insights
Anexelekto (AXL) is a transmembrane protein implicated in cancer and COVID-19. This study found AXL expression correlates with cancer prognosis and immune infiltration, suggesting AXL as a potential therapeutic target for cancer and viral vaccines.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- The SARS-CoV-2 virus constantly mutates, leading to global spread of variants like Omicron.
- Anexelekto (AXL), a transmembrane protein, influences cell growth, migration, and metastasis, and is implicated in cancer and COVID-19.
- AXL is highly expressed in respiratory system cells, unlike ACE2.
Purpose of the Study:
- To investigate the role of AXL expression in various cancer types.
- To explore the correlation between AXL expression, cancer prognosis, tumor mutation burden (TMB), and microsatellite instability (MSI).
- To analyze the relationship between AXL expression and immune cell infiltration in the tumor microenvironment.
Main Methods:
- Verification of AXL expression in cancerous and normal tissues.
- Correlation analysis of AXL expression with cancer prognosis, TMB, and MSI.
- Immune infiltration analysis in cancer patients, focusing on specific cancer types (BLCA, BRCA, CESC).
Main Results:
- AXL expression was strongly correlated with cancer prognosis, TMB, and MSI across most tumor types.
- A significant link was observed between AXL expression and immune scores in cancer patients, particularly in BLCA, BRCA, and CESC.
- Immune cells such as NK-cells, plasmacytoid dendritic cells, and myeloid dendritic cells showed high AXL expression within the tumor microenvironment.
Conclusions:
- AXL expression is a significant prognostic biomarker in cancer.
- AXL plays a crucial role in the tumor immune microenvironment.
- AXL-related tumor neoantigens present potential targets for developing novel cancer and SARS-CoV-2 vaccines.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Cancers Originate from Somatic Mutations in a Single Cell
Mechanisms of Retrovirus-induced Cancers
Selectins

